Imunon, Inc. (IMNN)
3.27
+0.20
(+6.51%)
USD |
NASDAQ |
Feb 06, 16:00
3.315
+0.04
(+1.38%)
After-Hours: 20:00
Imunon Research and Development Expense (TTM) : 7.524M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Cellectar Biosciences, Inc. | 14.55M |
| PDS Biotechnology Corp. | 19.15M |
| PAVmed, Inc. | 3.472M |
| ACADIA Pharmaceuticals, Inc. | 344.78M |
| Alnylam Pharmaceuticals, Inc. | 1.248B |